Skip to content
Los Angeles homelessness is surging and here's why, according to former LA Mayor Villaraigosa....
Today we'll evaluate Napier Port Holdings Limited (NZSE:NPH) to determine whether it could have potential as an......
AstraZeneca said that safety data on roxadustat underpinned the British drugmaker's hopes for the anaemia drug to become a standard treatment for patients with kidney disease. It said pooled data from several late-stage trials showed that roxadustat did not increase the risk of potentially deadly cardiovascular complications like heart attacks and strokes when used instead of epo, which is the standard treatment for dialysis patients against lack of red blood cells from kidney disease. For a subgroup of patients that had just recently gone on dialysis the cardiovascular risk was about one third lower for patients on roxadustat compared with those on epo, it added....
Nov.08 -- Scott McNealy, REX board member and Sun Microsystems co-founder, shares his views on the potential regulation of big technology with Bloomberg's David Westin on "Balance of Power."...
Chinese consumers are getting their wallets ready to fuel Alibaba's annual one-day shopping event....
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says......
